New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors: a Chinese population-based cohort study — Xinyi Gao (2023) | RDL Network
New-onset syncope in diabetic patients treated with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors: a Chinese population-based cohort study
Article 2023 en
Authors
XG
Xinyi Gao
NZ
Nan Zhang
LL
Lei Lü
Abstract
1 min read
Compared with DPP4i, SGLT2i was associated with a significantly lower risk of new-onset syncope in patients with T2DM, regardless of gender, age, degree of glycaemic control, and comorbidity burden.
Xinyi Gao, Nan Zhang, Lei Lü, Tianyu Gao, Oscar Hou In Chou, Wing Tak Wong, Carlin Chang, Abraham Ka Chung Wai, Professor Gregory Lip, Qingpeng Zhang, Gary Tse, Tong Liu, Jiandong Zhou
Oscar Hou In Chou, Tianyu Gao, Cheuk To Chung, Fengshi Jing, Jeffrey Shi Kai Chan, Danish Iltaf Satti, Ronald TK Pang, Sharen Lee, Wing Tak Wong, Tong Liu, Professor Gregory Lip, Bernard Man Yung Cheung, Gary Tse, Jiandong Zhou
Oscar Hou In Chou, Zhiyao Luo, Cheuk To Chung, Jeffrey Shi Kai Chan, Huixian Li, Ishan Lakhani, Sharen Lee, Qingpeng Zhang, Tong Liu, Wing Tak Wong, Bernard Man Yung Cheung, Professor Gregory Lip, Gary Tse, Fung Ping Leung, Jiandong Zhou
Discussion(0)
No comments yet. Be the first to comment.